← Leaderboards
Matthew B Soellner
University Of California Berkeley
$5,157,390
Attributed
$5,344,005
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $695.7K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,344,005 · 7
By mechanism
R01$3,499,093 · 2
R21$985,597 · 2
R00$747,000 · 1
K99$80,740 · 1
F32$31,575 · 1
Top collaborators
- Sofia Diana Merajver2 shared
Most similar at University Of California Berkeley
Same institution · by research overlap
- Amy Elizabeth Herr$8,197,415
- Markus August Seeliger$5,913,834
Others in their field
Top investigators on “Methodology”
- Jeffrey P Krischer · University Of South Florida$292,633,089
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- George R Seage · Abt Associates, Inc.$220,948,872
- Peter B. Gilbert · Fred Hutchinson Cancer Center$210,957,667
- Daniel Ernest Ford · Johns Hopkins University$158,461,124
Research focus
MethodologyInhibitor/AntagonistPlaySignal TransductionProteinsProtein KinaseKinase InhibitorPhosphotransferasesBiological ProcessSrc GeneComplexFda ApprovedMalignant NeoplasmsDesignMediatingBindingMutationPhosphorylationBiologicalApoptosisSignal PathwayTherapeutic TargetMolecular ConformationBase
Grant awards (22)
Conformational Control of Protein Kinases$313,763
R01 · FY2025 · GM · contact PI
Conformational Control of Protein Kinases$314,595
R01 · FY2024 · GM · contact PI
Conformational Control of Protein Kinases$315,394
R01 · FY2023 · GM · contact PI
Conformational Control of Protein Kinases$300,300
R01 · FY2020 · GM · contact PI
Conformational Control of Protein Kinases$300,300
R01 · FY2019 · GM · contact PI
Exquisitely selective turn-on probes of kinase activation and localization$223,722
R21 · FY2019 · CA · contact PI
Conformational Control of Protein Kinases$300,300
R01 · FY2018 · GM · contact PI
Exquisitely selective turn-on probes of kinase activation and localization$194,895
R21 · FY2018 · CA · contact PI
Integrative signaling to increase efficacy of targeted therapies for triple negative breast cancer$169,650
R21 · FY2018 · CA
Conformational Control of Protein Kinases$298,375
R01 · FY2017 · GM · contact PI
Integrative signaling to increase efficacy of targeted therapies for triple negative breast cancer$203,580
R21 · FY2017 · CA
Exquisitely selective turn-on probes of kinase activation and localization$193,750
R21 · FY2017 · CA · contact PI
Methodology for Identification of Substrate-Competitive Kinase Inhibitors$391,199
R01 · FY2012 · GM · contact PI
Methodology for Identification of Substrate-Competitive Kinase Inhibitors$293,147
R01 · FY2011 · GM · contact PI
Methodology for Identification of Substrate-Competitive Kinase Inhibitors$75,660
R01 · FY2011 · GM · contact PI
Methodology for Identification of Substrate-Competitive Kinase Inhibitors$296,393
R01 · FY2010 · GM · contact PI
Activity-based selections and amplification of non-natural protease substrates$249,000
R00 · FY2010 · RR · contact PI
Methodology for Identification of Substrate-Competitive Kinase Inhibitors$299,667
R01 · FY2009 · GM · contact PI
Activity-based selections and amplification of non-natural protease substrates$249,000
R00 · FY2009 · RR · contact PI
Activity-based selections and amplification of non-natural protease substrates$249,000
R00 · FY2008 · RR · contact PI
Activity-based selections and amplification of non-natural protease substrates$80,740
K99 · FY2007 · RR · contact PI
Fragment-Based Methodology for the Identification of Phosphatase Inhibitors$31,575
F32 · FY2007 · GM · contact PI